Clinical trial · Observational
Uterine Artery Embolization and Pelvic Floor Symptoms
Effect of Uterine Artery Embolization on Symptoms of Pelvic Floor Dysfunction
NCT00827645CI-TRIAL-00033050withdrawnClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): never funded and never started
Summary
Brief summary (as posted)
The objective of this study is to determine whether women who are already receiving treatment for their fibroids (ie. UAE) demonstrate improvement in urinary symptoms and sexual dysfunction as well.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Incontinence | — | UNRESOLVED | — |
| Leiomyoma | Leiomyoma | ONTOLOGY_EXACT | 0.98 |
| Prolapse | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Uterine artery embolization
- description
- Women with symptomatic uterine fibroids scheduled for uterine artery embolization
Primary outcomes (1)
- measure
- Urinary symptoms as demonstrated by questionnaires
- timeFrame
- 1 year
Secondary outcomes (1)
- measure
- Sexual dysfunction as defined by questionnaires
- timeFrame
- 1 year
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * female * age 18-80 years * symptomatic uterine fibroids * scheduled for UAE * Negative urine dipstick (negative result = trace or less for leukocytes \& nitrites) or negative UA or negative culture (Urine dipstick is performed as standard of care) * Available for 12-months of follow-up and able to complete study assessments, per clinician judgment * Signed consent form Exclusion Criteria: * Age \<18 or \>80 years * women who are unable to read and write English, * pregnancy or planned pregnancy in the next 12 months * \< 6 months postpartum * current use of anticholinergic medication, cholinergic agonists, tricyclic antidepressants, or duloxetine - must have been off such drugs for at least 4 weeks * women with surgery for urinary incontinence or pelvic organ prolapse in the past 6 months * history of bladder or pelvic cancer or pelvic radiation therapy * prior augmentation cystoplasty * urethral diverticulum, current or repaired.
References
Publications (0)
Data not yet available
No reference posted for this study.